Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing microbiologic response to antiinfective medications with incomplete data.

K F Phillips1

  • 1Advanced Biologics, LLC, Lambertville, New Jersey 08530, USA.

Journal of Biopharmaceutical Statistics
|May 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a pneumonia clinical pathway: quality and financial outcomes.

Outcomes management for nursing practice·1998
Same author

Proof of the independence of the AUC and the absorption rate.

Biopharmaceutics & drug disposition·1993
Same author

A log-normal model for individual bioequivalence.

Journal of biopharmaceutical statistics·1993
Same author

Response to "An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis" by White et al.

Journal of pharmacokinetics and biopharmaceutics·1992
Same author

Power of the two one-sided tests procedure in bioequivalence.

Journal of pharmacokinetics and biopharmaceutics·1990
Same author

Furazolidone for treatment of diarrhoeal disease.

Tropical doctor·1987

This study introduces a statistical model to estimate pathogen eradication rates in clinical trials, accounting for missing data and patient-specific factors. The model helps assess anti-infective treatment effectiveness and noninferiority.

Area of Science:

  • Biostatistics
  • Infectious Diseases
  • Clinical Trials

Background:

  • Clinical trials for anti-infective drugs need to measure pathogen eradication.
  • Estimating eradication rates is complex due to missing data and multiple pathogen species per patient.

Purpose of the Study:

  • To develop a statistical model for estimating pathogen eradication proportions (pi) in clinical trials.
  • To account for unknown pathogen responses and within-patient overdispersion.
  • To provide a method for testing noninferiority of anti-infective treatments.

Main Methods:

  • Utilized Poisson distribution for pathogen counts per patient.
  • Employed the beta-binomial model for pathogen eradication data.
  • Estimated parameters using maximum likelihood estimation.

Related Experiment Videos

  • Transformed parameters to estimate treatment differences and standard errors.

    • Main Results:

    • Developed a robust statistical model for pathogen eradication estimation.
    • The model effectively handles missing data and overdispersion.
    • Provided a framework for constructing confidence intervals for noninferiority testing.

    Conclusions:

    • The proposed statistical model accurately estimates pathogen eradication rates in anti-infective clinical trials.
    • This method improves the assessment of treatment efficacy when data are incomplete.
    • The approach supports rigorous noninferiority testing for new anti-infective therapies.